Indication

For the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.

Medicine details

Medicine name:
oritavancin (Orbactiv)
SMC ID:
SMC2285
Pharmaceutical company
Menarini Pharmaceuticals UK
BNF chapter
Skin
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC